NICE Issues Guidelines for Diagnosis, Management of Open Angle Glaucoma
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




NICE Issues Guidelines for Diagnosis, Management of Open Angle Glaucoma

LONDON -- April 21, 2009 -- The National Institute for Health and Clinical Excellence (NICE) and the National Clinical Guideline Centre will issue a guideline to improve the diagnosis and management of chronic open angle glaucoma (COAG) and ocular hypertension (OHT).

Available from 22 April, it will set out how best to diagnose COAG, how people with COAG, OHT or at risk of COAG should be monitored, and which treatments should be considered.

"Glaucoma can deprive people of their sight if it's not picked up early and treated, or if those at high risk of developing it aren't monitored closely," said Andrew Dillon, NICE, London, United Kingdom. "There is variation in current clinical practice, so this new NICE guideline means that for the first time we now have the means for a consistent national approach to managing glaucoma or suspected glaucoma, and high eye pressure."

"The recommendations will enable health professionals to provide the best care for people with glaucoma or at risk of developing it, helping reduce the long term impact of the condition on patients' vision and everyday lives," he said.

Recommendations from the guideline include:
· People who have COAG, who are suspected of having COAG or who have OHT should be offered a suite of tests including assessments of the eye pressure, the thickness of the cornea, the drainage area in the eye and field of vision, and an assessment and image of the appearance of the optic nerve heads.
· People at risk of developing glaucoma should be monitored regularly using tests similar to those used to diagnose glaucoma. The frequency of these tests will depend on how high the risk is of developing glaucoma.
· Clarity on monitoring intervals for testing people who have glaucoma or are at risk of developing it, and recommendations on follow-up of patients who turn out not to have glaucoma after a period of careful monitoring.
· Treatment with prostaglandins or beta-blockers to reduce high eye pressure in people with glaucoma or those at risk of the condition.
· After previous treatment switches, earlier consideration of alternative treatments for worsening glaucoma, such as surgery or laser treatment to avoid disease progression.

The guidance will be available at www.nice.org.uk/CG85

SOURCE: National Institute for Health and Clinical Excellence

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities